Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Amortization of Deferred Charges (2016 - 2018)

Historic Amortization of Deferred Charges for Surgery Partners (SGRY) over the last 5 years, with Q1 2018 value amounting to -$127000.0.

  • Surgery Partners' Amortization of Deferred Charges fell 10719.55% to -$127000.0 in Q1 2018 from the same period last year, while for Mar 2018 it was $5.6 million, marking a year-over-year decrease of 2644.76%. This contributed to the annual value of $7.2 million for FY2016, which is 1494.49% up from last year.
  • According to the latest figures from Q1 2018, Surgery Partners' Amortization of Deferred Charges is -$127000.0, which was down 10719.55% from $2.0 million recorded in Q2 2017.
  • Surgery Partners' 5-year Amortization of Deferred Charges high stood at $2.0 million for Q2 2017, and its period low was -$127000.0 during Q1 2018.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $1.7 million (2015), whereas its average is $1.5 million.
  • Per our database at Business Quant, Surgery Partners' Amortization of Deferred Charges surged by 4680.03% in 2016 and then tumbled by 10719.55% in 2018.
  • Surgery Partners' Amortization of Deferred Charges (Quarter) stood at $1.4 million in 2014, then fell by 4.0% to $1.3 million in 2015, then skyrocketed by 46.8% to $1.9 million in 2016, then grew by 5.51% to $2.0 million in 2017, then plummeted by 106.32% to -$127000.0 in 2018.
  • Its Amortization of Deferred Charges was -$127000.0 in Q1 2018, compared to $2.0 million in Q2 2017 and $1.8 million in Q1 2017.